A popular thyroid medication taken by 23 million Americans may be linked to bone loss, according to a new study. Levothyroxine – marketed under brand names such as Synthroid – is the second most commonly prescribed drug among older adults in the US. It is consumed by about 7% of the US population. The drug treats hypothyroidism, also known as underactive thyroid, by replacing or providing more of the thyroid hormone that is normally produced by the body. Study authors from Johns Hopkins Medicine linked levothyroxine use to greater bone loss and bone mineral density over six years — even in older adults with normal thyroid function, the nypost reports. The preliminary research compared the bone health of 81 levothyroxine users and 364 non-users, most of whom were in their early 70s. “The study shows that even when following the […]
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
